A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
The 2nd affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality Age range
18 Years – 70 Years
Last updated September 2025